Zai Lab Ltd Total Liabilities

Latest as of June 2026: $467.76 Million USD

Zai Lab Ltd total liabilities. Based on the latest financial reports, Zai Lab Ltd (ZLAB) has total liabilities worth $467.76 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ZLAB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Zai Lab Ltd (2015–2025)

Total liabilities of Zai Lab Ltd from 2015 to 2025. This chart illustrates how Zai Lab Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore ZLAB long-term investment intensity to see how much of total assets are deployed in long-term investments.

Zai Lab Ltd Competitors by Total Liabilities

The table below lists competitors of Zai Lab Ltd ranked by their total liabilities.

Company Country Total Liabilities
BSP Financial Group Ltd
AU:BFL
Australia AU$37.82 Billion
Sunway Construction Group Bhd
KLSE:5263
Malaysia RM3.78 Billion
Nanjing Tanker Corp
SHG:601975
China CN¥1.48 Billion
Ningbo Zhenyu Technology Co. Ltd.
SHE:300953
China CN¥7.75 Billion
HMS Networks AB (publ)
ST:HMS
Sweden Skr3.04 Billion
Zhejiang Publishing & Media Co Ltd
SHG:601921
China CN¥6.88 Billion
DHT Holdings Inc
NYSE:DHT
USA $469.69 Million
Guizhou Chanhen Chemical Corp
SHE:002895
China CN¥4.65 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Zai Lab Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zai Lab Ltd (ZLAB) total assets.

Liquidity & Leverage Metrics

Zai Lab Ltd Total Liabilities Ratios Explained

Zai Lab Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.77 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zai Lab Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zai Lab Ltd (2015–2025)

The table below shows the annual total liabilities of Zai Lab Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $456.88 Million +32.49%
2024-12-31 $344.86 Million +43.58%
2023-12-31 $240.18 Million +37.60%
2022-12-31 $174.54 Million -24.11%
2021-12-31 $230.00 Million +79.28%
2020-12-31 $128.29 Million +112.08%
2019-12-31 $60.49 Million +18.83%
2018-12-31 $50.91 Million +251.96%
2017-12-31 $14.46 Million -89.70%
2016-12-31 $140.46 Million +334.73%
2015-12-31 $32.31 Million --

About Zai Lab Ltd

NASDAQ:ZLAB USA Biotechnology
Market Cap
$2.56 Billion
Market Cap Rank
#5239 Global
#1768 in USA
Share Price
$22.80
Change (1 day)
+3.83%
52-Week Range
$16.30 - $27.00
All Time High
$191.71
About

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for … Read more